Delcath Systems, Inc.

NASDAQ:DCTH

Medical - Devices

Healthcare
$19.70 -1.91%

-$0.23 today

Market cap
$685.32M
Beta
0.52
P/E (TTM)
751.4
EPS (TTM)
$0.02
52W Low $8.12High $14.48

Volume 0.59M

Average 0.42M

DCTH Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Delcath Systems, Inc.NASDAQ: DCTH

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin narrows to 85.1%

Gross margin was 85.1% in Q1 FY2026, down 0.6 pp from a year earlier. On a trailing-twelve-month basis it was 86.0%, up 1.1 pp year over year. Over 3 fiscal years it widened by 11.4 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
85.1%-0.4 pp QoQ
Last fiscal yearDec 2025
86.2%+2.8 pp YoY
LTMMar 2026
86.0%+1.1 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-0.6 pp——
1 year+2.8 pp——
3 years+11.4 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
86.2%
Year-over-year change
+2.8pp

Gross Margin vs competitors

How DCTH compares with its peers on the latest reported figures

  • DCTH's LTM Mar 2026 gross margin of 86.0% is the highest of the 4 companies compared; the peer median is 75.2%.
  • Its year-over-year change of +1.1 pp is the highest of 4, against a peer median of -2.0 pp.
  • Over three fiscal years its change of +11.4 pp compares with a peer median of -4.1 pp.
DCTH Competitors Peer median
Gross Margin for DCTH and competitors
Company Period LTM level YoY 3-year change
DCTHDelcath Systems, Inc.LTM Mar 202686.0% +1.1 pp+11.4 pp
TLSITriSalus Life Sciences, Inc.LTM Mar 202685.1% -0.5 pp+2.8 pp
NVCRNovoCure LimitedLTM Mar 202675.2% -2.0 pp-4.1 pp
CATXPerspective Therapeutics, Inc.LTM Mar 2026-489.8% -407.5 pp-290.8 pp
Peer median (excluding DCTH) 75.2%-2.0 pp-4.1 pp

Competitors are the stored peer set for DCTH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue3.56M2.72M2.07M37.21M85.23M
Cost of Revenue671K686K635K6.19M11.8M
Gross Profit2.88M2.03M1.43M31.02M73.43M
Gross Margin81.1%74.8%69.2%83.4%86.2%
Research & Development13.78M18.58M17.5M13.87M29.25M
Selling, General & Admin13.64M17.3M22.11M29.55M43.53M
Operating Expenses27.42M35.89M39.61M43.43M72.77M
Depreciation & Amortization146K132K399K229K349K
EBITDA(24.32M)(33.69M)(45.84M)(26.16M)3.86M
EBITDA Margin-684.0%-1239.1%-2219.9%-70.3%4.5%
Operating Income(24.53M)(33.85M)(38.18M)(12.41M)660K
Operating Margin-690.0%-1245.1%-1849.0%-33.4%0.8%
Interest Income000125K2.92M
Interest Expense1.19M2.69M1.44M00
Other Income / Expenses(1.12M)(2.66M)(9.5M)(13.98M)2.85M
Income Before Tax(25.65M)(36.51M)(47.68M)(26.39M)3.51M
Pre-Tax Margin-721.5%-1342.7%-2308.9%-70.9%4.1%
Income Tax Expense0000810K
Net Income(25.65M)(36.51M)(47.68M)(26.39M)2.7M
Net Margin-721.5%-1342.7%-2308.9%-70.9%3.2%
EPS (Basic)(3.59)(4.12)(2.94)(0.93)0.08
EPS (Diluted)(3.59)(4.12)(2.94)(0.93)0.07
Weighted Avg Shares7.15M8.86M16.23M28.51M35.82M
Weighted Avg Shares (Diluted)7.15M8.86M16.23M28.51M39.92M

Delcath Systems, Inc.

NASDAQ:DCTH

Intrinsic Alpha fair value

Locked

Current Price

$19.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.